For instance, it has been shown that the loss or blockage of toll-like receptor 4 (TLR4), attenuates the development of NAFLD and alcohol-related liver diseases and improves insulin signaling in settings of type 2 diabetes [3,4,5]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.